Search Results - "Pulgar, S"

Anti‐viral therapy can be delayed or avoided in a significant proportion of HBeAg‐negative Caucasian patients in the Grey Zone by Bonacci, M., Lens, S., Mariño, Z., Londoño, M.‐C., Rodríguez‐Tajes, S., Mas, A., García‐López, M., Pérez‐del‐Pulgar, S., Sánchez‐Tapias, J. M., Forns, X.

“…Summary Background Grey Zone (GZ) is an ill‐defined situation including patients falling between inactive carrier (IC) state and HBeAg‐negative chronic…”
Get full text

The burden of Cushing's disease: clinical and health-related quality of life aspects by FEELDERS, R. A, PULGAR, S. J, KEMPEL, A, PEREIRA, A. M

“…Cushing's disease (CD) is a rare endocrine disorder characterized by excess secretion of ACTH due to a pituitary adenoma. Current treatment options are limited…”
Get full text

Hepatitis B reactivation in patients with chronic hepatitis C undergoing anti‐viral therapy with an interferon‐free regimen by Londoño, M.‐C., Lens, S., Mariño, Z., Bonacci, M., Ariza, X., Broquetas, T., Pla, A., Bartres, C., Adriani, M. V., Rodríguez‐Tajes, S., Costa, J., Carrión, J. A., Pérez‐del‐Pulgar, S., Forns, X.

“…Summary Background A few cases of hepatitis B virus (HBV) reactivation during anti‐viral therapy against hepatitis C (HCV) have been reported. However, the…”
Get full text

Donor and Recipient IL28B Polymorphisms in HCV‐Infected Patients Undergoing Antiviral Therapy before and after Liver Transplantation by Coto‐Llerena, M., Pérez‐del‐Pulgar, S., Crespo, G., Carrión, J. A., Martínez, S. M., Sánchez‐Tapias, J. M., Martorell, J., Navasa, M., Forns, X.

“…IL28B gene polymorphisms are associated with the response to antiviral therapy in hepatitis C patients. We investigated the influence of IL28B polymorphisms on…”
Get full text

Clinical, quality of life, and economic value of acromegaly disease control by Ben-Shlomo, A., Sheppard, M. C., Stephens, J. M., Pulgar, S., Melmed, S.

“…Although acromegaly is a rare disease, the clinical, economic and health-related quality of life (HRQoL) burden is considerable due to the broad spectrum of…”
Get full text

Real-world dosing patterns of patients (pts) with metastatic pancreatic cancer (mPC) treated with liposomal irinotecan (nal-IRI) in US oncology clinics by Ahn, D., Barzi, A., Miksad, R.A., Surinach, A., Corvino, F.A., Valderrama, A., Mamlouk, K., Pulgar, S., Bekaii-Saab, T.

Get full text

Characterization of the Cross‐Neutralizing Antibody Response Against Hepatitis C Virus in the Liver Transplantation Setting by Dragun, J., Pérez‐del‐Pulgar, S., Crespo, G., Ramírez, S., Coto‐Llerena, M., Mensa, L., García‐Valdecasas, J. C., Navasa, M., Forns, X.

“…Neutralizing antibody (nAb) activity during the course of natural infection is believed to be crucial to combating virus propagation. The aim of this study was…”
Get full text

Hepatitis C Virus Compartmentalization and Infection Recurrence after Liver Transplantation by Ramirez, S., Perez‐del‐Pulgar, S., Carrion, J. A., Costa, J., Gonzalez, P., Massaguer, A., Fondevila, C., Garcia‐Valdecasas, J. C., Navasa, M., Forns, X.

“…Hepatitis C virus (HCV) compartmentalization may have important implications in the pathogenesis of HCV infection. The aim of this study was to investigate the…”
Get full text

Lanreotide vs octreotide LAR for patients with advanced gastroenteropancreatic neuroendocrine tumors: An observational time and motion analysis by Ryan, P, McBride, A, Ray, D, Pulgar, S, Ramirez, RA, Elquza, E, Favaro, JP, Dranitsaris, G

“…Background Lanreotide and octreotide acetate suspension for injectable (LAR) are both recommended for clinical use in patients with locally advanced or…”
Get full text

Hepatitis C virus early kinetics and resistance-associated substitution dynamics during antiviral therapy with direct-acting antivirals by Mas, E.P, Caro-Pérez, N, Gregori, J, González, P, Bartres, C, Soria, M.E, Perales, C, Lens, S, Mariño, Z, Koutsoudakis, G, Quer, J, Forns, X, Pérez-del-Pulgar, S

Get full text

Preschool familial environment and academic difficulties: A 10-year follow-up from kindergarten to middle school by Câmara-Costa, H, Pulgar, S, Cusin, F, Dellatolas, G

“…The persistence of academic difficulties from childhood through adulthood has led researchers to focus on the identification of the early factors influencing…”
Get full text

Protection from inflammatory disease in insulin resistance: the role of mannan-binding lectin by Fernández-Real, J. M, Straczkowski, M, Vendrell, J, Soriguer, F, Pérez del Pulgar, S, Gallart, L, López-Bermejo, A, Kowalska, I, Manco, M, Cardona, F, García-Gil, M. M, Mingrone, G, Richart, C, Ricart, W, Zorzano, A

“…Aims/hypothesis Decreased sensing of the innate immune system may lead to chronic activation of the inflammatory cascade. We hypothesised that mannan-binding…”
Get full text

P227 P-BODY FORMATION IS IMPAIRED IN LIVERS FROM HCV-INFECTED PATIENTS by Fernández-Carrillo, C, Pérez-Vilaró, G, Mensa, L, Pérez-del-Pulgar, S, Forns, X, Díez, J

Get full text

P10 INTERFERON LAMBDA 4 (IFNL4) POLYMORPHISM PREDICTS RESPONSE TO HEPATITIS C TREATMENT AFTER LIVER TRANSPLANTATION by Fernández-Carrillo, C, González, P, Crespo, G, Coto-Llerena, M, Navasa, M, Forns, X, Pérez-del-Pulgar, S

Get full text

P1287 : Phylogenetic analysis of an epidemic outbreak of acute hepatitis C in HIV-infected patients by massive sequencing by Caro Pérez, N, Martinez-Rebollar, M, Gregori, J, Quer, J, González, P, Gambato, M, Visser, H, Esteban, J.I, Mallolas, J, Forns, X, Pérez-del-Pulgar, S, Laguno, M

Get full text

O108 : Residual HCV-RNA in liver explants from patients undergoing sofosbuvir and ribavirin treatment while awaiting liver transplantation is not associated with HCV relapse by Gambato, M, Pérez-del-Pulgar, S, Hedskog, C, Svarovskia, J, Paulson, M.S, Denning, J, Curry, M.P, Caro-Pérez, N, Londoño, M.C, Forns, X

Get full text

P0704 : Deep-sequencing analysis demonstrates the persistence of the pre-transplant HCV dominant variant within a more homogeneous quasispecies after liver transplantation in cholestatic hepatitis C patients by Gambato, M, Gregori, J, Quer, J, Caro-Perez, N, Gonzalez, P, Garcia-Cehic, D, Esteban, J.I, Crespo, G, Navasa, M, Forns, X, Perez-del-Pulgar, S

Get full text

In vivo and in vitro pharmacological characterization of SVT‐40776, a novel M 3 muscarinic receptor antagonist, for the treatment of overactive bladder by Salcedo, C, Davalillo, S, Cabellos, J, Lagunas, C, Balsa, D, Pérez‐del‐Pulgar, S, Ballarín, M, Fernández, AG

“…Background and purpose:  Highly selective M 3 muscarinic receptor antagonists may represent a better treatment for overactive bladder syndrome, diminishing…”
Get full text

Published costs of Medication errors leading to preventable adverse Drug events in US Hospitals by Pan, J, Mays, R, Gill, S, Albert, N.M, Patel, D, Stephens, J, Rocha-Cunha, C, Pulgar, S

Get full text

Deep-sequencing analysis demonstrates the persistence of pre-transplant HCV dominant variants within a more homogeneous quasispecies after liver transplantation (LT) in cholestatic hepatitis C patients by Gambato, M, Gregori, J, Quer, J, Caro-Pérez, N, Crespo, G, Navasa, M, Pérez-del-Pulgar, S, Forns, X

Get full text